BIRC5 and exocrine pancreatic carcinoma: In summary, our study investigating the role of B7-H3 in drug resistance has demonstrated that the protein confers resistance to gemcitabine in vitro and in vivo by reducing the sensitivity of pancreatic carcinoma cells to apoptosis, which is mediated via survivin expression.